Porcine torque teno virus antibody detection kit based on indirect immunofluorescence method and application thereof

Through the IFA method-based porcine parvovirus antibody detection kit, the Cap gene fusion protein antigen of TTSuV1 and TTSuV2 was solved, and the specificity and stability of TTSuV detection methods in the prior art were achieved. At the same time, efficient testing meets the needs of clinical testing.

CN119064577AActive Publication Date: 2024-12-03HENAN WILPIGO BIOTECHNOLOGY DEV CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411102276.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-12-03
Estimated Expiration
2044-08-12

AI Technical Summary

Technical Problem

Existing methods for detecting porcine parvovirus (TTSuV) are limited, especially for the lack of effective methods for simultaneous detection of TTSuV1 and TTSuV2. The ELISA method has specificity and stability problems, and no commercial kits are used to detect TTSuV antibodies.

Method used

Develop a porcine parvovirus antibody detection kit based on indirect immunofluorescence (IFA) method. By screening the relatively conserved sequences of the Cap genes of TTSuV1 and TTSuV2, fusion proteins are constructed as antigens, and combining IFA methods to achieve simultaneous antibiotics of TTSuV1 and TTSuV2. Test.

Benefits of technology

It improves the specificity and sensitivity of the kit, and can simultaneously and efficiently detect serum antibodies of TTSuV1 and TTSuV2, avoids the non-specific reaction and stability of the ELISA method, and meets the needs of TTSuV serological clinical testing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention relates to the technical field of in-vitro detection reagents, in particular to a porcine torque teno virus antibody detection kit based on an indirect immunofluorescence method and application of the porcine torque teno virus antibody detection kit. The porcine torque teno virus Cap antigen provided by the invention can be combined with serum antibodies induced by two genotypes of TTSuV1 and TTSuV2 at the same time, and has relatively high specificity. Based on the Cap antigen and an IFA method, the serological detection kit and the detection method for the TTSuV antibody are established, serum antibodies generated by induction of two genotype viruses TTSuV1 and TTSuV2 can be detected at the same time, the specificity, the stability and the repeatability are good, the problems occurring in the establishment process of an ELISA method are effectively avoided, and the kit and the method have good application prospects. The requirements of TTSuV serological clinical detection can be better met, and the method has a relatively good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of in vitro detection reagents, and in particular to a porcine parvovirus antibody detection kit based on an indirect immunofluorescence method and an application thereof. Background Art

[0002] Torque teno sus virus (TTSuV) is a small, non-enveloped single-stranded circular DNA virus belonging to the genus Torque tenovirus of the family Toriviridae. Its genome is about 2.8 kb long and contains 3-4 overlapping open reading frames (ORFs) and a non-coding region with high GC content. Torque teno sus virus was first discovered in 1997. After a blood transfusion, a non-enveloped single-stranded circular virus was detected in the serum of a Japanese patient with acute hepatitis. It was named TTV (TT Virus). Subsequently, TTV was also found in domestic animals such as pigs, chickens, cattle, sheep, cats and dogs.

[0003] TTSuV is divided into two genotypes, TTSuV1 and TTSuV2, and the genome similarity between the two is only about 50%. In recent years, TTSuV infection has been found in pigs in different countries. TTSuV is mainly transmitted through the fecal-oral route of animals, and can also be transmitted through vertical transmission routes such as placenta and uterus. TTSuV infection alone has no specific clinical symptoms, but TTSuV is often co-infected with other pig viruses such as porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV), which has some unknown synergistic effect and can aggravate the condition of animals.

[0004] At present, the existing TTSuV detection methods are limited to PCR for viral etiology detection or ELISA for serological detection. There is no commercial kit for the detection of TTSuV antibodies in clinical practice. Therefore, it is necessary to establish a rapid, efficient and sensitive TTSuV antibody detection method. In addition, there is still little research on the pathogenic mechanism of TTSuV. Carrying out sequence analysis of TTSuV and establishing its antibody detection method can provide an in-depth understanding of the virus infection in different pig herds, and provide a theoretical basis and technical support for the early detection and prevention and control of the virus.

[0005] Huang Yaowei et al. reported the TTSuV2 Western blot and ELISA antibody detection methods (DOI: 10.1016 / j.virusres.2011.03.013, and patent application CN201080047299). Yang Xiaoxiao et al. reported the establishment of an indirect ELISA antibody detection method for TTSuV1 (Yang Xiaoxiao et al., Journal of Beijing Agricultural College 2024, 39(1): 43-46). First, although the ELISA method has been widely used in the serological detection of many diseases, many kits still have many problems in terms of specificity and stability. An important reason for the above problems is that the ELISA coated plate used in this method has poor stability and large non-specific reaction. In addition, the antibody detection methods reported above are all for one of TTSuV2 and TTSuV1, and there is no kit that can detect antibodies of TTSuV1 and TTSuV2 at the same time. Summary of the invention

[0006] The invention provides a porcine parvovirus antibody detection kit based on an indirect immunofluorescence method (IFA) and an application thereof.

[0007] The invention analyzes and detects the prevalence of TTSuVs strains in large-scale pig farms in recent years, screens the prevalent strains of TTSuV1 and TTSuV2, selects relatively conservative sequences of the Cap genes of TTSuV1 and TTSuV2 in combination with the genome sequence analysis of TTSuV1 and TTSuV2, obtains a fusion protein simultaneously expressing part of the Cap genes of TTSuV1 and TTSuV2 through optimized combination, uses the fusion protein as an antigen molecule, and develops a TTSuV antibody detection kit based on an indirect immunofluorescence method.

[0008] Specifically, the present invention provides the following technical solutions.

[0009] In a first aspect, the present invention provides a porcine circovirus antibody detection kit based on an indirect immunofluorescence method, wherein the kit comprises cells expressing porcine circovirus Cap antigen; The amino acid sequence of the Cap antigen is shown in SEQ ID NO.1.

[0010] The specific sequence of SEQ ID NO.1 is shown below.

[0011] MPGDRFHSGIQDPSKVQNTVLNPWDYDCDGIVRKDTLKRLLELPTETEEEEPSRTLCADTPTEASQSAFLRGDEKEETSEGEETATSSSITSAESTTEGDGSSDDDETRK.

[0012] The above-mentioned Cap antigen is a fusion protein that contains partial capsid protein Cap fragments of both genotypes TTSuV1 and TTSuV2. It can simultaneously bind to serum antibodies against TTSuV1 and TTSuV2, has high specificity, can improve the specificity and sensitivity of the test kit, and can achieve simultaneous and efficient detection of serum antibodies against TTSuV1 and TTSuV2.

[0013] The cells described above carry the gene encoding the Cap antigen.

[0014] Based on the amino acid sequence of the Cap antigen and the codon coding rules, those skilled in the art can obtain the sequence of the gene encoding the Cap antigen. Based on the degeneracy of the codons, the sequence of the gene encoding is not unique, and all genes that can encode the Cap antigen are within the scope of protection of the present invention.

[0015] Preferably, the nucleotide sequence of the encoding gene is shown as SEQ ID NO.2.

[0016] The specific sequence of SEQ ID NO.2 is shown below.

[0017] GCCACCATGCCAGGAGACAGATTCCACAGCGGCATCCAGGACCCCAGCAAGGTGCAGAACACAGTGCTGAATCCTTGGGATTACGATTGCGACGGCATCGTGAGAAAGGATACACTGAAGAGACTGCTGGAGCTGCCCACAGAGACAGAGGAGGAGGAGCCCAGCAGGAC CCGTGTGCCGATACACCTACAGAGGCCAGCCAGTCCGCCTTTCGAGAGGCGACGAGAAGGAGGAGACCAGCGAGGGCGAGGAGACCGCCACATCCAGCTCCATCACATCCGCCGAGAGCAGCACCGAGGGCGACGGAAGCTCCGATGACGACGAGACCAGAAAGTGA.

[0018] The sequence shown in SEQ ID NO.2 comprises the expression-promoting sequence GCCACC and the coding sequence of the Cap antigen in order from 5' to 3'. The coding sequence of the Cap antigen is obtained by codon optimization. The coding gene sequence can significantly increase the expression level of the Cap antigen in host cells.

[0019] The cells described above are mammalian cell lines used for protein expression.

[0020] Preferably, the cells are HEK293T cells.

[0021] Preferably, the gene encoding the Cap antigen is located on a mammalian cell expression plasmid.

[0022] Further preferably, the mammalian cell expression plasmid is pcDNA3.1(+).

[0023] In some specific embodiments of the present invention, the pcDNA3.1(+) plasmid carrying the gene encoding the Cap antigen is introduced into HEK293T cells to obtain cells expressing the porcine parvovirus Cap antigen.

[0024] The cells expressing porcine circovirus Cap antigen described above are fixed in the wells of a perforated glass slide.

[0025] Preferably, the fixing can be performed using acetone.

[0026] In some specific embodiments of the present invention, the method for preparing the above-mentioned perforated slide fixed with cells expressing porcine circovirus Cap antigen comprises the following steps: introducing a DNA molecule containing a gene encoding the Cap antigen into an expression vector pcDNA3.1 (+), constructing a recombinant vector pcDNA-TTSuV-1, and transfecting it into HEK293T cells, then fixing the positively transfected cells on a slide with acetone, sealing the slide with alkaline glycerol, and placing it at -20°C for use.

[0027] To facilitate indirect immunofluorescence detection, the kit may further comprise one or more selected from a washing solution, a fluorescein-labeled secondary antibody, a positive standard control, a negative control, and a sealing agent.

[0028] Wherein, the fluorescein-labeled secondary antibody is used to bind to serum antibodies to achieve the detection of antigen-antibody complexes. Preferably, the fluorescein-labeled secondary antibody is FITC-labeled goat anti-swine IgG.

[0029] The washing solution is used to wash the glass slide after each step of reaction. Preferably, the washing solution is PBS buffer.

[0030] The sealing agent is used to seal the slide. Preferably, the sealing agent is alkaline glycerol.

[0031] The above-mentioned kit comprises the following steps when used to detect porcine parvovirus antibodies: Add the sample to be tested into the well of the perforated glass slide fixed with cells expressing porcine circovirus Cap antigen, and incubate at 35-37°C for 0.8-1.2h; After washing with washing solution, add fluorescein-labeled secondary antibody and incubate at 35-37℃ in the dark for 25-35min; After washing with washing solution, add sealing reagent to perform sealing and fluorescence observation; The fluorescence signal is used to determine whether the sample to be tested contains porcine circovirus antibodies.

[0032] In the present invention, the porcine parvovirus antibody is a serum antibody.

[0033] Preferably, the sample to be tested is pig serum.

[0034] In a second aspect, the present invention provides any of the following uses of the above-described kit: (1) Application in the preparation of products for detecting porcine parvovirus antibodies; (2) Use in the preparation of products for diagnosing porcine parvovirus infection; (3) Application in the detection of porcine parvovirus antibodies for non-disease diagnosis purposes.

[0035] In the above (1) and (3), the antibody is a pig serum antibody.

[0036] In a third aspect, the present invention provides an indirect immunofluorescence detection method for porcine parvovirus antibodies for non-disease diagnosis purposes, the method comprising: using the above-mentioned kit to detect a sample to be tested.

[0037] Preferably, the sample to be tested is pig serum.

[0038] Preferably, the above detection method comprises: Add the sample to be tested into the well of the perforated glass slide fixed with cells expressing porcine circovirus Cap antigen, and incubate at 35-37°C for 0.8-1.2h; After washing with washing solution, add fluorescein-labeled secondary antibody and incubate at 35-37℃ in the dark for 25-35min; After washing with washing solution, add sealing reagent to perform sealing and fluorescence observation; The fluorescence signal is used to determine whether the sample to be tested contains porcine circovirus antibodies.

[0039] In a fourth aspect, the present invention provides a porcine circovirus Cap antigen, the amino acid sequence of the Cap antigen is shown in SEQ ID NO.1.

[0040] Those skilled in the art will understand that the Cap antigen obtained by adding a protein tag, signal peptide, or the like to the N-terminus and / or C-terminus of the amino acid sequence as shown in SEQ ID NO.1, which does not affect the function of the amino acid sequence as shown in SEQ ID NO.1, is an equivalent variation of the Cap antigen as shown in SEQ ID NO.1, and is therefore also within the scope of protection of the present invention.

[0041] In a fifth aspect, the present invention provides a nucleic acid molecule encoding the porcine circovirus Cap antigen described above.

[0042] Based on the amino acid sequence of the Cap antigen and the codon encoding rules, those skilled in the art can obtain the sequence of the nucleic acid molecule encoding the Cap antigen. Based on the degeneracy of the codons, the sequence of the nucleic acid molecule is not unique, and all nucleic acid molecules capable of encoding the Cap antigen are within the scope of protection of the present invention.

[0043] In some embodiments of the present invention, the sequence of the nucleic acid molecule is shown as SEQ ID NO.2.

[0044] In a sixth aspect, the present invention provides a biological material, wherein the biological material comprises the nucleic acid molecule described above; the biological material is an expression cassette, a vector or a host cell.

[0045] The expression cassette described above is obtained by connecting the nucleic acid molecule with a promoter and one or more selected from a terminator, an enhancer, a translation promoting sequence, and the like.

[0046] The vectors mentioned above may be plasmid vectors, viral vectors, etc. Among them, plasmid vectors include replicative vectors, non-replicative vectors, etc.

[0047] The host cells described above include microbial cells or animal cells or animal cell lines. The microbial cells include but are not limited to Escherichia coli, yeast, etc. The animal cells can be any mammalian cell line used for protein expression, including but not limited to HEK293T cells.

[0048] In some specific embodiments of the present invention, a cell expressing porcine parvovirus Cap antigen is provided, wherein the cell is preferably a microbial cell or an animal cell (the animal cell does not have the potential to reproduce into an animal individual).

[0049] In a seventh aspect, the present invention provides any of the following uses of the porcine circovirus Cap antigen, the nucleic acid molecule or the biological material described above: (1) Application in the preparation of products for detecting porcine parvovirus antibodies; (2) Use in the preparation of products for diagnosing porcine parvovirus infection; (3) Application in the detection of porcine parvovirus antibodies for non-disease diagnosis purposes.

[0050] In an eighth aspect, the present invention provides a porcine circovirus detection reagent, the detection reagent comprising the porcine circovirus Cap antigen described above, or the detection reagent comprising a cell expressing the porcine circovirus Cap antigen described above, wherein the cell is preferably a microbial cell or an animal cell (the animal cell does not have the potential to reproduce into an animal individual).

[0051] The beneficial effects of the present invention include at least: the porcine circovirus Cap antigen provided by the present invention can simultaneously bind to serum antibodies induced by the two genotypes of TTSuV1 and TTSuV2, and has high specificity. Based on the Cap antigen and the IFA method, the present invention establishes a serological detection kit and detection method for TTSuV antibodies, which can simultaneously detect serum antibodies induced by the two genotype viruses of TTSuV1 and TTSuV2, and have good specificity, stability and repeatability, effectively avoiding the problems that occur during the establishment of the ELISA method, and can better meet the needs of TTSuV serological clinical detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0053] Figure 1 These are the expression test results of the porcine circovirus Cap antigen encoding gene sequence before and after optimization in Example 1 of the present invention.

[0054] Figure 2 Schematic diagram of a glass slide with holes in Example 2 of the present invention.

[0055] Figure 3 This is the result of TTSuV serum antibody detection using the IFA method in Example 3 of the present invention. DETAILED DESCRIPTION

[0056] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0057] Example 1: Design and expression optimization of porcine parvovirus Cap antigen

[0058] 1. Design of porcine circovirus Cap antigen

[0059] By analyzing and detecting the prevalence of TTSuVs strains in large-scale pig farms in recent years, the prevalent strains of TTSuV1 and TTSuV2 were screened, and combined with the genome sequence analysis of TTSuV1 and TTSuV2, the relatively conservative sequences of the Cap genes of TTSuV1 and TTSuV2 were selected, and a fusion protein expressing part of the Cap genes of TTSuV1 and TTSuV2 was obtained by optimizing the combination. The amino acid sequence of the fusion protein is shown in SEQ ID NO.1, and the coding sequence of the fusion protein is 333bp in length (the nucleotide sequence is shown in SEQ ID NO.3), among which positions 1-3 are the added start codon sequence ATG, positions 4-153 are from positions 1-150 of the Cap gene of TTSuV2 GD strain (JF937659), positions 154-330 are from positions 151-327 of the Cap gene of TTSuV1 HeN1-A9 strain (MW117137), and positions 331-333 are the added stop codon sequence TGA.

[0060] The specific sequence shown in SEQ ID NO.3 is as follows.

[0061] ATGCCCGGGGACCGCTTCCACAGCGGGATACAAGACCCCTCCAAGGTACAAAACACCGTCCTCAACCCCTGGGACTATGACTGTGATGGGATTGTTAGAAAAGATACTCTCAAAAGACTTCTCGAACTCCCCACAGAGACAGAGGAGGAGGAGCCGTCCAGAACCCT CTGTGCAGATACACCCACAGAAGCATCGCAAAGTGCATTTCTCAGAGGGGACGAAAAAGAGGAAACCTCGGAAGGAGAGGAAACCGCGACATCGTCCAGTATCACGAGTGCCGAAAGCTCTACTGAAGGAGATGGATCGTCTGATGATGATGAAACGAGAAAATGA.

[0062] 2. Optimization of expression of porcine circovirus Cap antigen

[0063] The coding sequence of the porcine circovirus Cap fusion protein (i.e., Cap antigen) in the above 1 (the nucleotide sequence is shown in SEQ ID NO.3) was codon-optimized and an expression-promoting sequence was added to increase the expression level of the porcine circovirus Cap antigen. After screening and verification, a Cap antigen encoding gene with codon optimization and addition of an expression-promoting sequence was obtained, and its nucleotide sequence is shown in SEQ ID NO.2.

[0064] The pcDNA3.1(+) empty vector, the pcDNA-TTSuV recombinant vector carrying the sequence shown in SEQ ID NO.3, and the pcDNA-TTSuV-1 recombinant vector carrying the sequence shown in SEQ ID NO.2 (codon optimized and expression-promoting sequence added) were transfected into HEK293T cells to obtain recombinant cells. The recombinant cells were cultured to obtain a cell suspension.

[0065] The expression level of porcine circovirus Cap antigen was detected, and the specific method is as follows.

[0066] (1) Take 20 μL of HEK293T cell suspension transfected with pcDNA3.1(+) empty vector, pcDNA-TTSuV recombinant vector and pcDNA-TTSuV-1 recombinant vector, add an equal volume of 2×SDS loading buffer, boil in boiling water bath for 8-10 min, take 20 μL of the treated sample and add it to the sample tank for SDS-PAGE electrophoresis.

[0067] (2) After electrophoresis, transfer the gel to NC membrane for Western Blot analysis. Place the NC membrane in β-actin monoclonal antibody, TTSuV antibody positive and negative serum, incubate at 37°C for 1 hour, wash with PBS buffer, add infrared fluorescent dye-labeled goat anti-mouse / pig-IgG secondary antibody, incubate at 37°C in the dark for 1 hour, wash with PBS buffer, scan the NC membrane with infrared scanning system Odyssey, and calculate the gray value of the band.

[0068] (3) The results are as follows Figure 1As shown, β-actin monoclonal antibody specifically reacted with HEK293T cells transfected with pcDNA3.1(+) empty vector, pcDNA-TTSuV recombinant vector and pcDNA-TTSuV-1 recombinant vector, and there was no significant difference in the grayscale value of the band; TTSuV1 and TTSuV2 positive pig sera specifically reacted with HEK293T cells transfected with pcDNA-TTSuV recombinant vector and pcDNA-TTSuV-1 recombinant vector, and the grayscale value of the band of HEK293T cells transfected with pcDNA-TTSuV-1 recombinant vector was 1.6 times that of HEK293T cells transfected with pcDNA-TTSuV recombinant vector; TTSuV1 and TTSuV2 positive pig sera did not react with HEK293T cells transfected with pcDNA3.1(+) empty vector. In addition, TTSuV1 and TTSuV2 negative pig sera did not react with HEK293T cells transfected with pcDNA3.1(+) empty vector, pcDNA-TTSuV recombinant vector, and pcDNA-TTSuV-1 recombinant vector. The above results show that the expression of Cap gene was significantly increased after codon optimization and the addition of expression-promoting sequences (the expression of Cap antigen increased by 1.6 times compared with that before optimization), and it can react specifically with TTSuV1 and TTSuV2 positive serum antibodies.

[0069] Example 2: Construction of a porcine parvovirus antibody detection kit based on the IFA method

[0070] 1 Materials and methods

[0071] 1.1 Materials

[0072] 1.1.1 Vectors and cells

[0073] The pcDNA3.1 (+) vector and HEK293T cells were stored by the Henan Provincial Animal Disease Diagnosis and Comprehensive Prevention and Control Engineering Technology Research Center of Nanyang Normal University, and can also be purchased through commercial channels. TTSuV1-positive pig serum, TTSuV2-positive pig serum and TTSuV-negative pig serum were prepared and stored by the inventor's laboratory. Porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus (CSFV) and pseudorabies virus (PRV) and other common swine virus-positive sera were stored in the inventor's laboratory. Clinical pig serum samples were collected from large-scale pig farms in different regions such as Nanyang City, Zhumadian City, Pingdingshan City, Xinyang City, Henan Province, Xiangyang City, Suizhou City, Shiyan City, Hubei Province, and stored in the inventor's laboratory.

[0074] 1.1.2 Main reagents

[0075] Plasmid extraction kit and gel recovery kit were purchased from Beijing Quanshijin Biotechnology Co., Ltd.; T4 DNA ligase, endonuclease Xhol I and Hind III were purchased from TaKaRa; DMEM cell culture medium, fetal bovine serum and cell culture bottles were purchased from Thermo; Lipofectamine 2000 transfection reagent and β-actin monoclonal antibody were purchased from Thermo Fisher Scientific; Sailing brand slides (with holes) were purchased from Yancheng Feizhou Plastic Co., Ltd.; FITC-labeled goat anti-swine IgG was purchased from Solarbio. The optimized TTSuV Cap gene sequence was synthesized by Sangon Biotech (Shanghai) Co., Ltd.

[0076] 1.2 Experimental methods

[0077] 1.2.1 Synthesis of TTSuV Cap antigen gene

[0078] The Hind III restriction site CGTAAGCTT and the expression-promoting sequence GCCACC were added upstream of the codon-optimized TTSuV Cap antigen coding sequence (as shown in positions 7-339 of SEQ ID NO.2, and the coding protein sequence is shown in SEQ ID NO.1), and the Xhol I restriction site CTCGAGTG was added downstream. It was synthesized by Sangon Biotech (Shanghai) Co., Ltd.

[0079] 1.2.2 Enzyme digestion and ligation

[0080] The synthesized TTSuV Cap antigen gene sequence and pcDNA3.1 (+) vector were double digested with nuclease Hind Ⅲ and Xhol I, respectively. The 40 μL reaction system was as follows: 4 μL 10× Fast Digest Buffer, 1.5 μL Hind Ⅲ, 1.5 μL Xhol I, 33 μL gene or vector template, mixed evenly and reacted in an air bath at 37°C for 1~2h. After enzyme digestion, agarose gel electrophoresis was performed respectively, and the correct fragments of the band were cut and recovered and purified. The obtained target gene and vector were connected with T4 ligase. The reaction system was as follows: 1 μL 10× Buffer, 1 μL T4 DNA ligase, 1 μL pcDNA3.1 (+) vector, 7 μL TTSuV Cap antigen gene template, mixed evenly and connected in an air bath at 22°C overnight.

[0081] 1.2.3 Recombinant vector construction

[0082] The ligation product in 1.2.2 was introduced into the competent cells of E. coli Top10 by heat shock transformation method, and then the cells were evenly spread on LB agar plates containing ampicillin, cultured at 37℃ for 12~14 h, and a single colony was picked and placed in LB liquid medium containing ampicillin. After 6 h of culture at 37℃, PCR detection was performed. The PCR reaction system was: 0.5μL of upstream and downstream primers, 5 μL of 2×PCR Mix, 1 μL of bacterial solution, and distilled water was added to a total volume of 10 μL. Then PCR amplification was performed, and the reaction procedure was: pre-denaturation at 95℃, 5 min; denaturation at 95℃, 30 s; annealing at 55℃, 30 s; extension at 72℃, 1 min; 35 cycles; 72℃, 10 min, followed by agarose gel electrophoresis detection. The upstream primer sequence is: CGTAAGCTTGCCACCATGCCCGGGGACC (SEQ ID NO.4); the downstream primer sequence is: CACTCGAGTCATTTTCTCGTTTCATCATCATC (SEQ ID NO.5). The bacterial solution with the correct target band size detected by PCR was sent to Sangon Biotech (Shanghai) Co., Ltd. for sequencing. The recombinant vector with the correct sequencing result was named pcDNA-TTSuV-1 and stored at -80℃ for future use.

[0083] 1.2.4 Cell transfection

[0084] First, pipette 4 μL of Lipofectamine 2000 transfection reagent into 246 μL of DMEM medium, gently pipette to mix, and let stand at room temperature for 2 min. Take 6 μg of pcDNA-TTSuV-1 vector into 250 μL of DMEM medium, gently pipette to mix, and let stand at room temperature for 2 min. Mix the two and let stand at room temperature for 15 min. Take out the HEK293T cells cultured in a 6-well plate for 48 hours, discard the medium, add DMEM medium to wash 3 times, then add transfection solution, and culture at 37℃ for 5 hours. Then discard the transfection solution, add 2mL of fresh DMEM medium, and culture at 37℃ for 48 hours to obtain positive transfected cells, which express the TTSuV Cap antigen shown in SEQ ID NO.1.

[0085] 1.2.5 Cytological smear

[0086] (1) Discard the culture medium of the 6-well plate and add PBS buffer for washing; (2) Add trypsin for digestion. After the cells fall off, gently blow to make a single-cell suspension, transfer to a 1.5 mL EP tube, and centrifuge at 5000 rpm for 5 min. (3) Discard the supernatant, add 1 mL of PBS buffer to the EP tube, gently blow the cells until mixed, and centrifuge at 5000 rpm for 5 min; (4) Discard the supernatant, add 200 μL PBS buffer to the EP tube, and gently pipette to mix. Figure 2 As shown, 20 μL of cell suspension was added to each well of the slide and allowed to dry at room temperature; (5) Fix the slide with pre-cooled acetone for 10-15 min, take it out and dry it, then place it at 4°C for later use.

[0087] A kit was constructed by combining the above-mentioned glass slide fixed with HEK293T cells expressing TTSuV Cap antigen and reagents required for IFA detection such as PBSA buffer.

[0088] Example 3: Preliminary establishment of IFA antibody detection method

[0089] Take the glass slides prepared in Example 2 with HEK293T cells expressing TTSuV Cap protein fixed thereon, add TTSuV antibody positive and negative serum, incubate at 37°C for 1 hour, wash with PBS buffer, add FITC-labeled goat anti-swine IgG, incubate at 37°C in the dark for 30 minutes, wash with PBS buffer, add alkaline glycerol to seal the slides, and then observe under a fluorescence microscope. The results are as follows Figure 3 As shown, both TTSuV1 and TTSuV2 positive pig sera reacted specifically with HEK293T cells transfected with pcDNA-TTSuV-1 recombinant vector, and green fluorescence was observed. They did not react with HEK293T cells transfected with pcDNA3.1(+) empty vector and normal HEK293T cells. TTSuV negative pig sera did not react with normal HEK293T cells, HEK293T cells transfected with pcDNA3.1(+) empty vector, and HEK293T cells transfected with pcDNA-TTSuV-1 recombinant vector. In addition, common swine virus positive sera such as PCV2, PRRSV, CSFV and PRV did not react with HEK293T cells transfected with pcDNA-TTSuV-1 recombinant vector. The above results showed that the transfected TTSuV Cap gene was transiently expressed in HEK293T cells and could only react specifically with TTSuV (TTSuV1 and TTSuV2) positive sera. A TTSuVIFA antibody detection method was preliminarily established, which can realize the simultaneous detection of TTSuV1 and TTSuV2 serum antibodies.

[0090] Example 4: Clinical application of IFA antibody detection method

[0091] 984 blood samples were collected from 20 large-scale pig farms in different regions such as Nanyang City, Zhumadian City, Pingdingshan City, Xinyang City, Henan Province, Xiangyang City, Suizhou City, and Shiyan City, Hubei Province, and the IFA method established in Example 3 was used to detect TTSuV antibodies in the blood samples. The results showed that 535 blood samples with positive TTSuV antibodies were detected, with a positive rate of 54.4%. The positive rates of TTSuV antibodies in different pig farms ranged from 18.0% to 76.1%, with relatively large differences (Table 1). Blood samples were collected from different groups of pigs in a large-scale pig farm, and TTSuV antibodies were detected using the IFA method established in Example 2. The results showed that the positive rate of TTSuV antibodies in nursery pigs was the lowest, at 18.0%, and the positive rate of TTSuV antibodies in multiparous sows was the highest, at 78.0%. The positive rates of fattening pigs and gilts were 44.0% and 64.0%, respectively. From nursery pigs to fattening pigs, gilts, and multiparous sows, the proportion of TTSuV infection gradually increased (Table 2).

[0092] Table 1 TTSuV antibody test results in sera from different pig farms

[0093] Table 2 TTSuV antibody detection results of different groups of pig sera

[0094] The above results show that the IFA antibody detection method established in the present invention has good specificity, stability and repeatability, can provide an in-depth understanding of the infection situation of TTSuV in pig herds, and provide a theoretical basis and technical support for the early detection and prevention and control of the virus.

[0095] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A porcine parvovirus antibody detection kit based on indirect immunofluorescence method, characterized in that: The kit comprises cells expressing porcine parvovirus Cap antigen; The amino acid sequence of the Cap antigen is shown in SEQ ID NO.

1.

2. The kit according to claim 1, characterized in that The cell carries the gene encoding the Cap antigen; Preferably, the nucleotide sequence of the encoding gene is shown as SEQ ID NO.

2.

3. The kit according to claim 2, characterized in that The cell is a mammalian cell line for protein expression; Preferably, the cell is a HEK293T cell; Preferably, the gene encoding the Cap antigen is located on a mammalian cell expression plasmid; The mammalian cell expression plasmid is preferably pcDNA3.1(+).

4. The kit according to any one of claims 1 to 3, characterized in that The cells expressing porcine circovirus Cap antigen are fixed in the wells of a perforated glass slide; Preferably, the kit further comprises one or more selected from a washing solution, a fluorescein-labeled secondary antibody, a positive standard control, a negative control, and a sealing agent; Preferably, the kit comprises the following steps when used to detect porcine parvovirus antibodies: Add the sample to be tested into the well of the perforated glass slide fixed with cells expressing porcine circovirus Cap antigen, and incubate at 35-37°C for 0.8-1.2h; After washing with washing solution, add fluorescein-labeled secondary antibody and incubate at 35-37℃ in the dark for 25-35min; After washing with washing solution, add sealing reagent to perform sealing and fluorescence observation; Judging whether the sample to be tested contains porcine parvovirus antibodies according to the fluorescent signal; Preferably, the sample to be tested is pig serum.

5. Any of the following uses of the kit according to any one of claims 1 to 4: (1) Application in the preparation of products for detecting porcine parvovirus antibodies; (2) Use in the preparation of products for diagnosing porcine parvovirus infection; (3) Application in the detection of porcine parvovirus antibodies for non-disease diagnosis purposes.

6. An indirect immunofluorescence detection method for porcine parvovirus antibodies for non-disease diagnosis purposes, characterized in that: The method comprises: using the kit according to any one of claims 1 to 4 to detect a sample to be tested; Preferably, the sample to be tested is porcine serum; Preferably, the method comprises: Add the sample to be tested into the well of the perforated glass slide fixed with cells expressing porcine circovirus Cap antigen, and incubate at 35-37°C for 0.8-1.2h; After washing with washing solution, add fluorescein-labeled secondary antibody and incubate at 35-37℃ in the dark for 25-35min; After washing with washing solution, add sealing reagent to perform sealing and fluorescence observation; The fluorescence signal is used to determine whether the sample to be tested contains porcine circovirus antibodies.

7. A porcine parvovirus Cap antigen, characterized in that: The amino acid sequence of the Cap antigen is shown in SEQ ID NO.

1.

8. A nucleic acid molecule, characterized in that The nucleic acid molecule encodes the porcine parvovirus Cap antigen according to claim 7; Preferably, the nucleotide sequence of the nucleic acid molecule is as shown in SEQ ID NO.

2.

9. Biomaterial, characterized in that The biological material comprises the nucleic acid molecule according to claim 8; the biological material is an expression cassette, a vector or a host cell.

10. Any one of the following uses of the porcine circovirus Cap antigen according to claim 7, the nucleic acid molecule according to claim 8, or the biological material according to claim 9: (1) Application in the preparation of products for detecting porcine parvovirus antibodies; (2) Use in the preparation of products for diagnosing porcine parvovirus infection; (3) Application in the detection of porcine parvovirus antibodies for non-disease diagnosis purposes.

Citation Information

Patent Citations

  • Porcine torque teno virus vaccines and diagnosis

    CN102712930A

  • Infectious clones of Torque teno virus

    CN102655871A

  • Porcine circovirus type 3 Cap recombinant protein and coding gene thereof and application thereof

    CN109762052A

  • Porcine circovirus type 4 ELISA antibody detection kit, application and method for detecting porcine circovirus type 4 antibody

    CN112345767A

  • Porcine circovirus type 3 Cap recombinant protein, coding gene thereof and application of porcine circovirus type 3 Cap recombinant protein in ELISA antibody detection

    CN114014916A